Abstract
Hypothalamic and pituitary disorders usually impair statural growth. These disorders may be either congenital or acquired with differences in clinical presentation. Growth failure is mainly related to growth hormone deficiency (GHD) that can be accompanied by other pituitary hormone deficiencies. The onset of clinical features may be insidious and unnoticed for years or decades. Therefore, it is important to periodically assess auxologic data such as height, growth velocity, bone maturation and evaluate hormonal levels related to hypothalamic–pituitary axis in these patients. Magnetic resonance imaging (MRI) greatly improved the study of central nervous system (CNS) disorders including the hypothalamic–pituitary region. Currently, it is an essential tool in the definition of the etiology of GHD. It can detect tumors that may require surgical intervention, and also provide insights into other causes of GHD. Catch up growth of congenital disorders is essentially dependent on hormone replacement. Even with an initial diagnosis of IGHD, attention should be given to the risk of the development of multiple pituitary hormone deficiencies. In addition to the hormonal deficiencies due to the acquired disorder themselves; their treatment (surgery, irradiation, chemotherapy) often leads to combined pituitary deficits. Growth responsiveness to rhGH has safety aspects of treatment which deserve additional discussion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ACTH:
-
Adrenocortical-stimulating hormone
- Afp:
-
Alpha-fetoprotein
- BMI:
-
Body mass index
- CNS:
-
Central nervous system
- CPP:
-
Central precocious puberty
- CT:
-
Computed tomography
- DI:
-
Diabetes insipidus
- EPP:
-
Ectopic posterior pituitary
- GH1 :
-
Growth hormone 1 gene
- GHRHR :
-
Growth hormone-releasing hormone receptor gene
- GLI2 :
-
GLI-KRUPPEL family member gene 2
- GH:
-
Growth hormone
- GHBP:
-
Growth hormone binding protein
- GHD:
-
Growth hormone deficiency
- GHRH:
-
growth hormone-releasing hormone
- HESX1 :
-
Homeobox embryonic stem cell 1 gene
- hCG:
-
Human chorionic gonadotropin
- IGF-1:
-
Insulin-like growth factor 1
- IGFBP-3:
-
Insulin-like growth factor binding protein 3
- IGHD:
-
Isolated growth hormone deficiency
- LCH:
-
Langerhans cell histiocytosis
- LHX4 :
-
Lim Homeobox 4 gene
- MPHD:
-
Multiple pituitary hormone deficiency
- MRI:
-
Magnetic resonance imaging
- OTX2 :
-
Orthodenticle, drosophila, homolog of, 2 gene
- Pit1 :
-
Pou Domain, Class1, Transcription factor 1, POU1F1 gene
- PROP1 :
-
Prophet of pit 1 gene
- rhGH:
-
Recombinant human growth hormone
- SDS:
-
Standard deviation score
- SOD:
-
Septo-optic dysplasia
- SOX2 :
-
SRY-BOX 2 gene
- SOX3 :
-
SRY-BOX 3 gene
- T4:
-
Levothyroxine
- TBI:
-
Traumatic brain injury
- TSH:
-
Thyroid-stimulating hormone
References
Abdel Razek AAK, Kandell AY, Elsorogy LG, Elmongy A, Basett AA. Disorders of cortical formation: MR imaging features. AJNR. 2009;30:4–11.
Acerini CL, Tasker RC. Traumatic brain injury induced hypothalamic-pituitary dysfunction: a paediatric perspective Pituitary. Pituitary. 2007;10:373–80.
Argyropoulou MI, Kiortsis D. MRI of the hypothalamic-pituitary axis in children. Pediatr Radiol. 2005;35:1045–55.
Barkovich AJ, Fram EK, Normand D. Septo-optic dysplasia: MR imaging. Radiology. 1989;171:189–92.
Bihan H, Christozova V, Dumas JL, Jomaa R, Valeyre D, Tazi A, Reach G, KRrivitzky A, Cohen R. Sarcoidosis: clinical, hormonal, and magnetic resonance imaging (MRI) manifestations of hypothalamic-pituitary disease in 9 patients and review of the literature. Medicine (Baltimore). 2007;86:259–68.
Blethen SL, Baptista J, Kuntze J, Foley T, Lafranchi S, Johanson A. Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study Group. J Clin Endocrinol Metab. 1997;82:418–20.
Bonneville F, Cattin F, Marsot-Dupuch K, Dormond D, Bonneville JF, Chiras J. T1 signal hyperintensity in the sellar region: spectrum of findings. Radiographics. 2006;26:93–113.
Bucher H, Zapf J, Torresani T, Prader A, Froesch ER, Illig R. Insulin-like growth factors I and II, prolactin, and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngioma. N Engl J Med. 1983;309:1142–6.
Byrd S. Magnetic resonance imaging of supratentorial congenital brain malformations. J Natl Med Assoc. 1989;81:873–81.
Caldarelli M, Di Ricco C. Diagnosis of Chiari I malformation and related syringomyelia: radiological and neurophysiological studies. Childs Nerv Syst 2004;20:332–5.
Cannavo S, Venturino M, Curto L, De Menis E, D’arrigo C, Tita P, Billleci D, Trimarchi F. Clinical presentation and outcome of pituitary adenomas in teenagers. Clin Endocrinol (Oxf). 2003;58:519–27.
Chen S, Leger J, Garel C, Hassan M, Czernichow P. Growth hormone deficiency with ectopic neurohypophysis: anatomical variations and relationship between the visibility of the pituitary stalk asserted by magnetic resonance imaging and anterior pituitary function. J Clin Endocrinol Metab. 1999;84:2408–13.
Cole TJ, Hindmarsh PC, Dunger DB. Growth hormone (GH) provocation tests and the response to GH treatment in GH deficiency. Arch Dis Child. 2004;89:1024–7.
Costalonga EF, Antonini SR, Guerra-Junior G, Mendonca BB, Arnhold IJ, Jorge AA. The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency. J Clin Endocrinol Metab. 2009;94:588–95.
Costalonga EF, Jorge AA, Mendonca BB, Arnhold IJ. [Mathematical models for predicting growth responses to growth hormone replacement therapy]. Arq Bras Endocrinol Metabol. 2008;52:839–49.
Cottier JP, Destrieux C, Brunereau L, Bertrand L, Bertrand P, Moreau L, Jan M, Herbreteau D. Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology. 2000;215:463–9.
Coutant R, Rouleau S, Despert F, Magontier N, Loisel D, Limal JM. Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings. J Clin Endocrinol Metab. 2001;86:4649–54.
Cutfield W, Lindberg A, Albertsson Wikland K, Chatelain P, Ranke MB, Wilton P. Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board. Acta Paediatr Suppl. 1999;88:72–5.
Darzy KH, Shalet SM. Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary. 2005;8:203–11.
de Boer H, van der Veen EA. Why retest young adults with childhood-onset growth hormone deficiency? J Clin Endocrinol Metab. 1997;82:2032–6.
de Ridder MA, Stijnen T, Hokken-Koelega AC. Prediction of adult height in growth-hormone-treated children with growth hormone deficiency. J Clin Endocrinol Metab. 2007;92:925–31.
Delman BN, Fatterpekar GM, Law M, Naidich TP. Neuroimaging for the pediatric endocrinologist. Pediatr Endocrinol Rev. 2008;5:708–19.
Dutta P, Bhansali A, Singh P, Bhat MH. Suprasellar tubercular abscess presenting as panhypopituitarism: a common lesion in an uncommon site with a brief review of literature. Pituitary. 2006;9:73–7.
Freeman JL, Zacharin M, Rosenfeld JV, Harvey AS. The endocrinology of hypothalamic hamartoma surgery for intractable epilepsy. Epileptic Disord. 2003;5:239–47.
Frindik JP. Pituitary morphologic anomalies and magnetic resonance imaging in pediatric growth hormone deficiency. Endocrinologist. 2001;11(4):289–95.
Frisch H, Birnbacher R. Final height and pubertal development in children with growth hormone deficiency after long-term treatment. Horm Res. 1995;43:132–4.
Gabriel Zada BD, Mcnatt SA, Gordon Mccomb J, Krieger MD. Surgical treatment of rathke cleft cysts in children. Neurosurgery. 2009;64:1132–8.
Garcia-Filion P, Epport K, Nelson M, Azen C, Geffner ME, Fink C, Borchert M. Neuroradiographic, endocrinologic, and ophthalmic correlates of adverse developmental outcomes in children with optic nerve hypoplasia: a prospective study. Pediatrics. 2008;121:e653–9.
GH Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab. 2000;85:3990–3.
Gottschling S, Graf N, Meyer S, Reinhard H, Krenn T, Rohrer T. Intracranial germinoma: a rare but important differential diagnosis in children with growth retardation. Acta Paediatr. 2006;95:302–5.
Guyda HJ. Four decades of growth hormone therapy for short children: what have we achieved? J Clin Endocrinol Metab. 1999;84:4307–16.
Johnsen DE, Woodruff WW, Allen IS, Cera PJ, Funkhouser GR, Colemn LL. MR imaging of the sellar and juxtasellar regions. Radiographics. 1991;11:727–58.
Jorge AA, Arnhold IJ. Growth hormone receptor exon 3 isoforms and their implication in growth disorders and treatment. Horm Res. 2009;71 Suppl 2:55–63.
Jostel AS, Shallet SM. In: Ranke MB, Price DA, Reiter EO, editors. Growth hormone therapy in pediatrics – 20 years of KIGS. Childhood brain tumours and growth hormone treatment. Basel, Karger, 2007, pp. 240–249
Jung H, Neumaier Probst E, Hauffa BP, Partsch CJ, Dammann O. Association of morphological characteristics with precocious puberty and/or gelastic seizures in hypothalamic hamartoma. J Clin Endocrinol Metab. 2003;88:4590–5.
Karavitaki N, Cudlip S, Adams CB, Wass JA. Craniopharyngiomas. Endocr Rev. 2006a;27:371–97.
Karavitaki N, Warner JT, Marland A, Shine B, Ryan F, Arnold J, Turner HE, Wass JA. GH replacement does not increase the risk of recurrence in patients with craniopharyngioma. Clin Endocrinol (Oxf). 2006b;64:556–60.
Kristrom B, Wikland KA. Growth prediction models, concept and use. Horm Res. 2002;57 Suppl 2:66–70.
Kucharczyk W, Bishop JE, Plewes DB, Keller MA, George S. Detection of pituitary microadenomas: comparison of dynamic keyhole fast spin-echo, unenhanced, and conventional contrast-enhanced MR imaging. AJR. 1994;163:671–9.
Kunii N, Abe T, Kawako M, Tanioka D, Izumiyama H, Moritani T. Rathke’s cleft cysts: differentiation from other cystic lesions in the pituitary fossa by use of single-shot fast spin-echo diffusion-weighted MR imaging. Acta Neurochir (wien). 2007;149:759–69.
Lam KS, Sham MM, Tam SC, Ng MM, Ma HT. Hypopituitarism after tuberculous meningitis in childhood. Ann Intern Med. 1993;118:701–6.
Leger J, Danner S, Simon D, Garel C, Czernichow P. Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood. J Clin Endocrinol Metab. 2005;90:650–6.
Longobardi S, Merola B, Pivonello R, Di Rella F, Di Somma C, Colao A, Ghigo E, Camanni F, Lombardi G. Reevaluation of growth hormone (GH) secretion in 69 adults diagnosed as GH-deficient patients during childhood. J Clin Endocrinol Metab. 1996;81:1244–7.
Machinis K, Pantel J, Netchine I, Leger J, Camand OJ, Sobrier ML, Dastot-Le Moal F, Duquesnoy P, Abitbol M, Czernichow P, Amselem S. Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet. 2001;69:961–8.
Maghnie M, Ambrosini L, Cappa M, Pozzobon G, Ghizzoni L, Ubertini MG, Di Iorgi N, Tinelli C, Pilia S, Chiumello G, Lorini R, Loche S. Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies. J Clin Endocrinol Metab. 2006;91:2900–5.
Maghnie M, Ghirardello S, Genovese E. Magnetic resonance imaging of the hypothalamus-pituitary unit in children suspected of hypopituitarism: who, how and when to investigate. J Endocrinol Invest. 2004;27:496–509.
Maghnie M, Strigazzi C, Tinelli C, Autelli M, Cisternino M, Loche S, Severi F. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. J Clin Endocrinol Metab. 1999;84:1324–8.
Mcnay DE, Turton JP, Kelberman D, Woods KS, Brauner R, Papadimitriou A, Keller E, Keller A, Haufs N, Krude H, Shalet SM, Dattani MT. HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. J Clin Endocrinol Metab. 2007;92:691–7.
Mendonca BB, Osorio MG, Latronico AC, Estefan V, Lo LS, Arnhold IJ. Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301,G302 in the PROP1 gene. J Clin Endocrinol Metab. 1999;84:942–5.
Mitchell LA, Thomas PQ, Zacharin MR, Scheffer IE. Ectopic posterior pituitary lobe and periventricular heterotopia: cerebral malformations with the same underlying mechanism? AJNR. 2002;23:1475–81.
Miyamoto J, Hasegawa Y, Ohnami N, Onigata K, Kinoshita E, Nishi Y, Tachibana K, Hasegawa T. Development of growth hormone and adrenocorticotropic hormone deficiencies in patients with prenatal or perinatal-onset hypothalamic hypopituitarism having invisible or thin pituitary stalk on magnetic resonance imaging. Endocr J. 2001;48:355–62.
Moon RJ, Wilson P, Kirkham FJ, Davies JH. Growth monitoring following traumatic brain injury. Arch Dis Child. 2009;94:699–701.
Morris KP, Coulthard MG, Smith PJ, Craft AW. Renovascular and growth effects of childhood sarcoid. Arch Dis Child. 1996;75:74–5.
Muller HL. Recent advances in diagnosis, treatment and follow-up. Horm Res. 2008;69:193–202.
Nash J, Cheng JS, Meyer GA, Remler BF. Chiari type I malformation: overview of diagnosis and treatment. WMJ. 2002;101:35–40.
Price DA. In: Ranke MB, Price DA, Reiter EO, editors. Growth hormone therapy in pediatrics – 20 years of KIGS. Growth hormone treatment of children with previous craniopharyngioma: the KIGS experience. Basel: Karger; 2007.
Price DA, Wilton P, Jonssona P, Albertsson-Wikland K, Chatelain P, Cutfield W, Ranke MB. Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996. Horm Res. 1998;49:91–7.
Ranke MB. Acta Paediatr Scand Suppl. 1987;331:80–2.
Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH deficiency: analysis of data from KIGS. J Clin Endocrinol Metab. 2005;90:1966–71.
Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study. J Clin Endocrinol Metab. 1999;84:1174–83.
Ranke MB, Price DA, Albertsson-Wikland K, Maes M, Lindberg A. Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Analysis of 195 Patients of the Kabi Pharmacia International Growth Study. Horm Res. 1997;48:62–71.
Ranke MB, Price DA, Reiter EO. Growth hormone therapy in pediatrics – 20 years of KIGS. Basel: Karger; 2007.
Rao VJ, James RA, Mitra D. Imaging characteristics of common suprasellar lesions with emphasis on MRI findings. Clin Radiol. 2008;63:939–47.
Reiter EO, Price DA, Wilton P, Albertsson-Wikland K, Ranke MB. Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database. J Clin Endocrinol Metab. 2006;91:2047–54.
Reiter EO, Rosenfeld RG. Normal and aberrant growth. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, editors. Williams textbook of endocrinology. 10th ed. Philadelphia, PA: WB Saunders; 2002; pp. 1003–1114.
Rumboldt Z. Pituitary adenomas. Top Mag Reson Imaging. 2005;16:277–88.
Rupp D, Molitch M. Pituitary stalk lesions. Curr Opin Endocrinol Diabetes Obes. 2008;15:339–45.
Sanford RA. Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery. Pediatr Neurosurg. 1994;21 Suppl 1:39–43.
Savage MO, Chan LF, Grossman AB, Storr HL. Work-up and management of paediatric Cushing’s syndrome. Curr Opin Endocrinol Diabetes Obes. 2008;15:346–51.
Schonau E, Westermann F, Rauch F, Stabrey A, Wassmer G, Keller E, Bramswig J, Blum WF. A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency. Eur J Endocrinol. 2001;144:13–20.
Shalet SM, Gibson B, Swindell R, Pearson D. Effect of spinal irradiation on growth. Arch Dis Child. 1987;62:461–4.
Tajima T, Ohtake A, Hoshino M, Amemiya S, Sasaki N, Ishizu K, Fujieda K. OTX2 loss of function mutation causes anophthalmia and combined pituitary hormone deficiency with a small anterior and ectopic posterior pituitary. J Clin Endocrinol Metab. 2009;94:314–9.
van der Werff ten Bosch JJ, Bot A. Clin Endocrinol (Oxf). 1990;32:707–17.
Webb EA, Dattani MT. Septo-optic dysplasia. Eur J Human Genet. 2009;22, epub ahead.
Wit JM, Kamp GA, Rikken B. Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature. Pediatr Res. 1996;39:295–302.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Carvalho, L.R. et al. (2012). Catch-Up Growth in Patients with Congenital or Acquired Growth Hormone Deficiency After GH Replacement: Clinical Features and Hypothalamic–Pituitary Imaging. In: Preedy, V. (eds) Handbook of Growth and Growth Monitoring in Health and Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1795-9_57
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1795-9_57
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1794-2
Online ISBN: 978-1-4419-1795-9
eBook Packages: MedicineMedicine (R0)